Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Brain Functional Sector-guided Intermittent Theta Burst Stimulation Therapy Targeting at the Superior Temporal Gyrus for Aphasia After Ischemic Stroke: a RCT

NCT05929534 is registered in ClinicalTrials.gov with Changping Laboratory as lead sponsor.

NCT NCT05929534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05929534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Brain Functional Sector-guided Intermittent Theta Burst Stimulation Therapy Targeting at the Superior Temporal Gyrus for Aphasia After Ischemic Stroke: a RCT
Lead sponsor
Changping Laboratory
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2023
Completion date
June 30, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, stroke, ischemic